NCT00212758View on ClinicalTrials.gov

A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in Blood

PHASE4CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2010

Conditions
Kidney Failure, ChronicGrowth Hormone Deficiency
Interventions
DRUG

Nutropin AQ

Nutropin AQ

Trial Locations (8)

77030

Texas Children's Hospital, Houston

UT Houston Medical School, Houston

92350

Loma Linda UMC & Children's Hospital, Loma Linda

97227

Legacy Emanuel Children's Hospital, Portland

97239

Oregon Health & Science University, Portland

98105

University of Washington, Children's Hospital & Regional Medical Center, Seattle

90095-1752

University of California in Los Angeles (UCLA), Los Angeles

94305-5208

Stanford University Medical Center, Stanford

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

Oregon Health and Science University

OTHER

NCT00212758 - A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in Blood | Biotech Hunter | Biotech Hunter